Skip to main content

Diagnostic options ยท UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00โ€“30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 991โ€“1005 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3225
Tacrolimus (FK506) Therapeutic Drug Monitoring Test

This test measures the concentration of tacrolimus (FK506) in whole blood to guide immunosuppressive therapy in transplant patients.

Whole blood (EDTA) Same-day (sample received by 5 PM) 750.00 AED
View
View test specifications and preparation
What it measures
["Tacrolimus (FK506) concentration", "Therapeutic drug level"]
Parameters
[{"name": "Tacrolimus (FK506)", "reference_range": null}]
Preparation
["Collect sample immediately before the next scheduled dose (trough level).", "Record the exact dosing time and amount."]
Indications
["Post-transplant monitoring", "Dose adjustment guidance", "Assessment of drug efficacy and toxicity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3991-7 ICD-10: Z51.81
Clinical summary
This test measures the concentration of tacrolimus (FK506) in whole blood to guide immunosuppressive therapy in transplant patients.
TEST-4873
TAF2 Gene MRT40 Genetic Test

This test identifies pathogenic variants in the TAF2 gene associated with autosomal recessive mental retardation type 40 (MRT40).

Peripheral Whole Blood 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in TAF2 gene exons and splice sites"]
Parameters
[]
Preparation
[]
Indications
["Suspected MRT40", "Confirmatory testing for intellectual disability", "Targeted family screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82306-7 ICD-10: F70, F79
Clinical summary
This test identifies pathogenic variants in the TAF2 gene associated with autosomal recessive mental retardation type 40 (MRT40).
TEST-1089
Targeted Mutation Analysis (1 Mutation) Test

This test identifies the presence or absence of a single, pre-specified genetic mutation using Sanger sequencing.

Peripheral whole blood (EDTA or ACD tube) 10โ€“15 working days 1,200.00 AED
View
View test specifications and preparation
What it measures
["Specific DNA sequence variant"]
Parameters
[]
Preparation
["Inform healthcare provider about all medications, supplements, or herbal products"]
Indications
["Diagnosis of hereditary conditions", "Risk assessment for genetic disorders", "Personalized management of genetic conditions", "Known familial mutation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 84452-4 ICD-10: Z13.79
Clinical summary
This test identifies the presence or absence of a single, pre-specified genetic mutation using Sanger sequencing.
TEST-6152
TARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 21 Genetic Test

This genetic test identifies pathogenic variants in the TARS2 gene associated with Combined Oxidative Phosphorylation Deficiency Type 21.

Whole Blood (EDTA), Extracted DNA, or Buccal Swab (FTA Card) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TARS2 gene"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist of all medications and supplements"]
Indications
["Suspected Combined Oxidative Phosphorylation Deficiency Type 21", "Family screening for TARS2 variants"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88883-9 ICD-10: E88.49
Clinical summary
This genetic test identifies pathogenic variants in the TARS2 gene associated with Combined Oxidative Phosphorylation Deficiency Type 21.
TEST-4410
TBC1D24 Gene Familial Infantile Myoclonic Epilepsy Genetic Test

This test detects pathogenic variants in the TBC1D24 gene associated with familial infantile myoclonic epilepsy.

Peripheral Whole Blood (EDTA tube) or FTA Card Dried Blood Spot 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TBC1D24 gene", "Synaptic vesicle trafficking protein alterations"]
Parameters
[]
Preparation
["Pre-test genetic counselling session is mandatory", "Document family history and construct a three-generation pedigree"]
Indications
["Suspected familial infantile myoclonic epilepsy", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94037-1 ICD-10: G40.4
Clinical summary
This test detects pathogenic variants in the TBC1D24 gene associated with familial infantile myoclonic epilepsy.
TEST-3237
TBG (Thyroxine Binding Globulin) Test

This diagnostic test evaluates the concentration of thyroxine-binding globulin (TBG) in the blood.

Serum or Plasma (Peripheral Blood) 2โ€“3 Weeks (Batch Processing) 1,800.00 AED
View
View test specifications and preparation
What it measures
["Thyroxine Binding Globulin (TBG) concentration", "Thyroid hormone carrier protein levels"]
Parameters
[{"name": "Thyroxine Binding Globulin (TBG)", "reference_range": null}]
Preparation
["No special fasting required", "Sign Sendโ€‘Out Consent Form (Form 35)", "Keep samples refrigerated if collected at home"]
Indications
["Evaluation of thyroid hormone binding capacity", "Interpretation of free T3 and free T4 levels", "Diagnosis of inherited TBG deficiency or excess", "Assessment in liver disease or estrogen therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 14903-0 ICD-10: E07.9, E07.8, Z13.29
Clinical summary
This diagnostic test evaluates the concentration of thyroxine-binding globulin (TBG) in the blood.
TEST-4563
TBR1 Gene Genetic Test for Intellectual Disability

This test identifies pathogenic variants within the TBR1 gene using Next-Generation Sequencing (NGS). It is used to diagnose TBR1-related neurodevelopmental disorders.

Whole Blood, Extracted DNA, FTA Card (dried blood spot) 3 โ€“ 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TBR1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of TBR1-related neurodevelopmental disorders", "Genetic clarification for intellectual disability", "Evaluation of autism spectrum disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82370-6 ICD-10: F78.9
Clinical summary
This test identifies pathogenic variants within the TBR1 gene using Next-Generation Sequencing (NGS). It is used to diagnose TBR1-related neurodevelopmental disorders.
TEST-2210
TBX3 Gene Ulnar-Mammary Syndrome Genetic Test

This test evaluates the entire coding region of the TBX3 gene for pathogenic variants associated with Ulnar-Mammary Syndrome (ULMM). It assesses hereditary cancer predisposition re...

Peripheral Whole Blood (EDTA tube) or FTA Card Finger-Prick 3โ€“4 Weeks (21โ€“28 calendar days); urgent expedite available upon request 2,800.00 AED
View
View test specifications and preparation
What it measures
["TBX3 gene coding region variants", "Large deletions/duplications in TBX3 gene"]
Parameters
[]
Preparation
["No specific fasting required", "No medication adjustments needed unless advised by physician"]
Indications
["Diagnosis of Ulnar-Mammary Syndrome (ULMM)", "Assessment of hereditary cancer predisposition", "Predictive testing for at-risk family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 78941-3 ICD-10: Q87.2
Clinical summary
This test evaluates the entire coding region of the TBX3 gene for pathogenic variants associated with Ulnar-Mammary Syndrome (ULMM). It assesses hereditary cancer predisposition related to TBX3 mutations.
TEST-3118
TBXAS1 Gene Thromboxane Synthase Deficiency Genetic Test

This test identifies pathogenic variants in the TBXAS1 gene associated with thromboxane synthase deficiency, a rare inherited platelet disorder.

Whole Blood (EDTA) or Dried Blood Spot (FTA Card) 21โ€“28 Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TBXAS1 gene", "Platelet aggregation function (indirectly via genetic cause)"]
Parameters
[{"name": "Analytical Sensitivity", "reference_range": ">99.9%"}, {"name": "Analytical Specificity", "reference_range": ">99.9%"}]
Preparation
["No special preparation such as fasting is needed", "Avoid strenuous exercise for 24 hours before collection"]
Indications
["Suspected thromboxane synthase deficiency", "Evaluation of inherited platelet disorders", "Recurrent unexplained bleeding"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94465-9 ICD-10: D69.1
Clinical summary
This test identifies pathogenic variants in the TBXAS1 gene associated with thromboxane synthase deficiency, a rare inherited platelet disorder.
TEST-4580
TCTN3 Gene Joubert Syndrome Type 18 Genetic Test

This genetic test identifies pathogenic variants within the TCTN3 gene associated with Joubert syndrome type 18.

Whole Blood (Peripheral) 21โ€“28 Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TCTN3 gene", "Single-nucleotide variants (SNVs)", "Small insertions and deletions (indels)"]
Parameters
[{"name": "Molecular Coverage", "reference_range": "Full gene coverage (exons, splice sites, deep intronic regions) with uniform read depth"}, {"name": "Analytical Sensitivity", "reference_range": ">99.9% for single-nucleotide variants and small indels"}, {"name": "Diagnostic Yield", "reference_range": ">99.9% for SNVs/indels"}]
Preparation
[]
Indications
["Individuals presenting with clinical features suggestive of Joubert syndrome type 18", "Carrier testing", "Prenatal confirmation", "Variant of uncertain significance resolution"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q04.3
Clinical summary
This genetic test identifies pathogenic variants within the TCTN3 gene associated with Joubert syndrome type 18.
TEST-3547
TDRD7 Gene Cataract, Autosomal Recessive Congenital Type 4 Genetic Test

This test identifies pathogenic variants in the TDRD7 gene associated with autosomal recessive congenital cataract type 4 (ARCC4).

Peripheral Whole Blood, Dried Blood Spot (FTA card), or Extracted DNA 3โ€“4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TDRD7 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy-number changes (exon level)"]
Parameters
[]
Preparation
["No fasting required", "Genetic counselling session mandatory for informed consent and pedigree chart"]
Indications
["Diagnosis of autosomal recessive congenital cataract type 4 (ARCC4)", "Carrier screening", "Family planning", "Guiding early surgical intervention"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81258-2 ICD-10: Q12.0
Clinical summary
This test identifies pathogenic variants in the TDRD7 gene associated with autosomal recessive congenital cataract type 4 (ARCC4).
TEST-1084
TEL/AML1 Qualitative Test

This test detects the presence of the ETV6-RUNX1 fusion transcript, a common genetic marker in B-cell acute lymphoblastic leukemia (ALL).

Bone Marrow Aspirate or Peripheral Blood 3โ€“4 days 600.00 AED
View
View test specifications and preparation
What it measures
["ETV6-RUNX1 fusion transcript", "Presence of specific genetic fusion"]
Parameters
[]
Preparation
["No fasting required", "Inform healthcare team about all current medications", "Valid DHA-licensed physician prescription is mandatory"]
Indications
["Diagnosis of B-cell acute lymphoblastic leukemia (ALL)", "Risk stratification in ALL", "Minimal residual disease (MRD) monitoring in ALL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 49797-6 ICD-10: C91.0
Clinical summary
This test detects the presence of the ETV6-RUNX1 fusion transcript, a common genetic marker in B-cell acute lymphoblastic leukemia (ALL).
TEST-3552
TENM1 Gene Colobomatous Microphthalmia Genetic Test

This diagnostic test evaluates the TENM1 gene for pathogenic variants associated with colobomatous microphthalmia.

Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TENM1 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number changes"]
Parameters
[]
Preparation
["No fasting required", "Pre-test genetic counselling session mandatory", "Provide previous ophthalmology reports", "Legal guardian accompaniment required for minors"]
Indications
["Clinical suspicion of colobomatous microphthalmia", "Family history of colobomatous microphthalmia", "Need for recurrence risk counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48018-6 ICD-10: Q11.2, Q12.2
Clinical summary
This diagnostic test evaluates the TENM1 gene for pathogenic variants associated with colobomatous microphthalmia.
TEST-3240
Testosterone & SHBG Test

This test evaluates total testosterone and SHBG levels to calculate free testosterone, aiding in the diagnosis of androgen imbalances.

Serum Same Day (Sample by 9 AM Sun-Thu) 550.00 AED
View
View test specifications and preparation
What it measures
["Total Testosterone", "Sex Hormone Binding Globulin (SHBG)", "Calculated Free Testosterone"]
Parameters
[{"name": "Total Testosterone", "reference_range": null}, {"name": "SHBG", "reference_range": null}, {"name": "Free Testosterone (Calculated)", "reference_range": null}]
Preparation
["No fasting required.", "Morning draw (8โ€“10 AM) recommended.", "Inform phlebotomist of all medications and supplements."]
Indications
["Diagnosis of hypogonadism", "Diagnosis of PCOS", "Evaluation of androgen imbalances", "Monitoring hormone replacement therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 2986-8, 13460-4 ICD-10: E29.1, E28.2
Clinical summary
This test evaluates total testosterone and SHBG levels to calculate free testosterone, aiding in the diagnosis of androgen imbalances.
TEST-2981
TFAP2B Gene Char Syndrome Genetic Test

This genetic test evaluates the TFAP2B gene for mutations associated with Char syndrome.

Peripheral whole blood (or FTA card for neonates) 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TFAP2B gene sequence", "Single nucleotide variants (SNVs)", "Insertions/Deletions (indels)", "Mosaic mutations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions or transplants"]
Indications
["Suspected Char syndrome", "Family history of Char syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81319-5 ICD-10: Q87.8
Clinical summary
This genetic test evaluates the TFAP2B gene for mutations associated with Char syndrome.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area